as 11-14-2024 12:30pm EST
Stocks
Adagio Medical Holdings Inc is an innovator in catheter ablation technologies for treatment of cardiac arrhythmias. The company focuses on developing innovative cryoablation technologies that create contiguous, transmural lesions to treat cardiac arrhythmias, including paroxysmal and persistent atrial fibrillation, atrial flutter, and ventricular tachycardia.
Upcoming Earnings Alert:
Get ready for potential market movements as ADAGIO MEDICAL HOLDINGS INC ADGM prepares to release earnings report on 19 Nov 2024.
Founded: | 2011 | Country: | United States |
Employees: | N/A | City: | LAGUNA HILLS |
Market Cap: | 37.1M | IPO Year: | N/A |
Target Price: | N/A | AVG Volume (30 days): | 120.4K |
Analyst Decision: | N/A | Number of Analysts: | N/A |
Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
EPS: | -45.18 | EPS Growth: | N/A |
52 Week Low/High: | $2.33 - $9.34 | Next Earning Date: | 11-19-2024 |
Revenue: | $399,000 | Revenue Growth: | 58.73% |
Revenue Growth (this year): | N/A | Revenue Growth (next year): | N/A |
ADGM Breaking Stock News: Dive into ADGM Ticker-Specific Updates for Smart Investing
Business Wire
10 days ago
Business Wire
22 days ago
Business Wire
a month ago
Business Wire
3 months ago
The information presented on this page, "ADGM ADAGIO MEDICAL HOLDINGS INC - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.